Department of Pathology, Xuzhou Medical University, 209 Tong-shan Road, Jiangsu, 221004, Xuzhou, China.
Invest New Drugs. 2021 Aug;39(4):1123-1131. doi: 10.1007/s10637-021-01070-0. Epub 2021 Jan 27.
Ferroptosis is a type of oxidative stress-dependent regulated necrosis characterized by excessive lipid peroxide accumulation. This novel cell death modality has been implicated in preventing cancer progression. Cancer cells tend to modulate their redox state to prevent excessive peroxidation, eventually facilitating tumor growth. System Xc (a cystine/glutamate antiporter system) is a promising target in cancer cells for ferroptosis induction. The overexpression of system Xc, especially its core subunit xCT, has been reported in several tumors, and these high expression levels were closely related to cancer cell proliferation, invasion, metastasis and the tumor microenvironment. xCT might serve as a novel biomarker, and its upregulation almost always indicates drug tolerance and poor survival. Therefore, system Xc inhibition may enhance chemotherapy sensitivity and optimize patient prognosis. Here, we elaborate on the mediation of ferroptosis by suppressing system Xc and the relevant underlying molecular mechanism in cancer cells. The spotlight on this approach to cancer treatment is creating a new horizon and pointing to future opportunities.
铁死亡是一种依赖于氧化应激的调节性细胞坏死,其特征是脂质过氧化物的积累过多。这种新的细胞死亡方式被认为可以预防癌症的进展。癌细胞往往会调节其氧化还原状态,以防止过氧化物的过度积累,最终促进肿瘤的生长。系统 Xc(半胱氨酸/谷氨酸反向转运蛋白系统)是诱导铁死亡的癌症细胞中的一个有前途的靶点。系统 Xc 的过表达,特别是其核心亚基 xCT,在几种肿瘤中都有报道,这些高表达水平与癌细胞的增殖、侵袭、转移和肿瘤微环境密切相关。xCT 可能作为一种新的生物标志物,其上调几乎总是预示着药物耐受和预后不良。因此,抑制系统 Xc 可能会增强化疗的敏感性并优化患者的预后。在这里,我们详细阐述了抑制系统 Xc 对铁死亡的介导作用及其在癌细胞中的相关分子机制。这种针对癌症治疗的新方法正在开辟新的视野,并为未来提供了机会。